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Abstract
Background: Although high-density lipoprotein-cholesterol (HDL) level is inversely correlated with cardiovascular
events, HDL is also reported to be positively associated with hypertension, which is a known endothelial
impairment factor. Since HDL mediates important protective actions on the vascular endothelium by increasing the
number of circulating endothelial progenitor cells (CD34-positive cells), the level of circulating CD34-positive cells
should influence the association between HDL and hypertension.
Methods: To investigate the association between HDL and hypertension in relation to the level of circulating
CD34-positive cells, we conducted a cross-sectional study of 477 elderly men aged 60–69 years who participated in
general health checkup.
Results: HDL was found to be significantly positively associated with hypertension in subjects with a high level of
circulating CD34-positive cells, while no significant association was observed for subjects with low circulating CD34-
positive cells. Known cardiovascular risk factors adjusted odds (ORs) and 95% confidence intervals (CIs) of
hypertension for increments of one standard deviation (SD) in HDL (13.8 mg/dL) were 1.44 (1.06, 1.96) for subjects
with a high level of circulating CD34-positive cells and 0.87 (0.63, 1.19) for subjects with low circulating CD34-
positive cells. We also revealed a significant association between HDL level and CD34-positive cell level on
hypertension, with fully adjusted p values for the effect of this interaction on hypertension at 0.022.
Conclusions: Independent of known cardiovascular risk factors, HDL was found to be positively associated with
hypertension in subjects with a high level of circulating CD34-positive cells but not for subjects with low circulating
CD34-positive cells.
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Backgrounds
A previous Japanese study reported hypertension as an
important risk factor for coronary disease [1]. Addition-
ally, low levels of high-density lipoprotein-cholesterol
(HDL) are associated with increased risk of coronary
artery disease [2]. These studies led us to speculate that
low levels of HDL are associated with a higher prevalence of
hypertension. However, a previous Japanese cross-sectional
study reported that HDL is independently positively associ-
ated with hypertension in apparently healthy Japanese men
and women [3].
Recently, numerous studies have reported a bidirec-
tional association between hypertension and endothelial
dysfunction—hypertension induces increased arterial
stiffness and vice versa [4–10]. The cycle between hyper-
tension and endothelial dysfunction has been established,
and the process of endothelial repair should also play an
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important role with regard to breaking away from this
vicious cycle.
On the other hand, bone marrow-derived endothelial
progenitor cells such as CD34-positive cells have been
reported to contribute to endothelial repair [11–13], and
circulating CD34-positive cells contribute to the main-
tenance of cerebral circulation in an ischemic stress set-
ting. A strong inverse correlation between the number
of circulating CD34-positive cells and cerebral infarction
has been shown [14]. Another study reported an inverse
correlation between the level of cognitive impairment
and the number of circulating CD34-positive cells in
patients with vascular-type cognitive impairment [15].
Therefore, subjects with a high level of CD34-positive cells
should have elevated endothelial repair activity [6, 16–18].
Since endothelial repair activity should be stimulated by
endothelial injury, subjects with a high level of CD34-
positive cells should present with endothelial injury simi-
lar to participants with stable cardiovascular disease and
acute coronary syndrome. In addition to the above, unlike
HDL from healthy subjects, HDL from participants with
stable cardiovascular disease or acute coronary syndrome
is reported to be lacking in endothelial anti-inflammatory
effects and does not stimulate endothelial repair [19].
Given the above, we hypothesized that the positive
association between HDL and hypertension occurs only
in subjects with a high level of circulating CD34-positive
cells.
To investigate this association, we conducted a cross-
sectional study of 477 elderly men aged 60–69 years




This study was approved by the Ethics Committee for
Human use of Nagasaki University (project registration
number: 14051404). Written consent forms were avail-
able in Japanese to ensure comprehensive understanding
of the study objectives, and informed consent was pro-
vided by the participants.
The study population comprised 617 male residents
aged 60–69 years from the Western rural communities
of Goto city and Saza town, who undertook a general
medical checkup from 2013 to 2015 as recommended by
the Japanese government. Persons with missing labora-
tory measurement data (n = 44) and smoking status data
(n = 1) were excluded from the study population. To
avoid the influence of inflammatory disease and
hematological disease, subjects with high and low white
blood cell count (≥1,000 cells/μL) (n=8) and 1,000 cells/
μL< (n=2), respectively) were also excluded. Addition-
ally, since a decline in glomerular filtration rate (GFR)
was identified as a marker of chronic kidney disease
(CKD), this should act as a confounding factor in the
present study, and we therefore excluded 85 subjects
with CKD. The remaining participants, comprising 477
men with a mean age of 65.4 years (standard deviation
(SD) 2.6, range 60–69), were enrolled in the study.
Hypertension, diabetes, hypercholesterolemia, and current
smoker status are regarded as traditional cardiovascular
risk factors [20]. Given that renal function, alcohol con-
sumption, and hepatic enzyme levels are also important
risk factors for the incidence of stroke [21, 22], and hyper-
uricemia is associated with carotid atherosclerosis [23], we
also recognize these factors as being related to the known
cardiovascular risk factors.
Data collection and laboratory measurements
Body weight and height were measured with an automatic
body composition analyzer (BF-220; Tanita, Tokyo, Japan),
and body mass index (BMI; kg/m2) was calculated.
Systolic and diastolic blood pressures were recorded at
rest. Hypertension was defined as a systolic blood pressure
≥140 mmHg and/or a diastolic blood pressure ≥90 mmHg
and/or taking antihypertensive medication, as described in
previous studies [24, 25], since hypertension defined under
these parameters was reported to be associated with the
incidence of stroke and coronary artery disease in the Jap-
anese population [1].
Fasting blood samples were collected in an EDTA-2K
tube, a heparin sodium tube and a siliconized tube. The
levels of white blood cells in samples from the EDTA-2K
tube were measured at SRL, Inc (Tokyo, Japan).
Fresh samples (within 24 h of collection) from a hep-
arin sodium tube were used to determine the number of
CD34-positive cells. BD (Beckton Dickinson Biosciences,
Franklin Lakes, New Jersey, USA) Trucount™ technol-
ogy, an accurate and reproducible single platform assay
conforming to the International Society of Hematother-
apy and Graft Engineering (ISHAGE) guidelines [26, 27]
and supported by automated software on the BD FACS-
CantoTM II system was used to measure the number of
circulating CD34-positive cells. Serum samples were sep-
arated to measure the concentration of aspartate amino-
transferase (AST) and γ-glutamyltranspeptidase (γ-GTP)
using the Japanese Society Clinical Chemistry (JSCC)
standardized method. Serum creatinine was measured en-
zymatically. HDL and low-density lipoprotein-cholesterol
(LDL) were measured using a direct method, while
hemoglobin A1c (HbA1c) was measured using the latex
coagulation method. Serum uric acid (UA) was measured
enzymatically using the uricase peroxidase (POD) method.
GFR was estimated by means of an established method
that was recently proposed by the working group of the
Japanese Chronic Kidney Disease Initiative [28]. Accord-
ing to this adapted version, GFR (mL/min/1.73 m2) =
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194 × (serum creatinine (enzyme method))−1.094 × (
age)−0.287. CKD is defined as a GFR < 60 mL/min/1.73 m2.
Statistical analyses
Differences in mean values or prevalence of potential con-
founding factors based on circulating CD34-positive cell
levels were calculated. An age-adjusted trend test was per-
formed with a regression model for mean values, and a lo-
gistic regression model was used for proportion. Since the
number of circulating CD34 cells should indicate the pres-
ence of underlying endothelial repair activity [6, 14–18] and
0.99 cells/μL was the median value of the circulating CD34-
positive cells in our present study, this value was set as the
cutoff point, as in our previous study [6]. Logistic regression
models were used to calculate odds ratios (ORs) and 95%
confidence intervals (CIs) to determine the influence of
HDL on hypertension, and subjects were stratified accord-
ing to the level of circulating CD34-positive cells (high,
low). To avoid the influence of medication on HDL values,
we also calculated ORs and 95% CIs of hypertension for in-
crements of one standard deviation (SD) in ORs and 95%
CIs stratified by circulating CD34-positive levels (high, low)
limited to subjects not taking lipid-lowering medication.
Adjustments for confounding factors that we defined
as known cardiovascular risk factors were made in three
ways. First, we adjusted only for age. Second, we made a
further adjustment for BMI based on the following: BMI
has been reported to be positively associated with the
level of circulating CD34-positive cells, which is divided
by median values of such cells among the general
population [6], and inversely associated with circulating
CD34-positive cells predominantly among subjects with
a high BMI (31.6 ± 5.1 kg/m2) [29]. In addition, unlike
other cardiovascular risk factors, BMI is reported to be
inversely associated with HDL-cholesterol [30] and posi-
tively associated with hypertension [31]. Therefore, BMI
might act as the strongest confounding factor in the
present study. Finally, for the third adjustment, we
included other possible confounding factors, including
Age (year) and BMI (kg/m2), smoking status (never
smoker, former smoker, current smoker), alcohol con-
sumption [never drinker, former drinker, current drinker
(23 g/week ≤ <46 g/week, 46 g/week ≤ <69 g/week, 69 g/
week≤)], HbA1C (%), LDL (mg/dL), AST (IU/L), γ-GTP
(IU/L), UA (mg/dL) and GFR (mL/min/1.73 m2).
All statistical analyses were performed using the
SAS system for Windows (version 9.4; SAS Inc., Cary,
NC). All p values for statistical tests were two-tailed,
with values of <0.05 regarded as being statistically
significant.
Results
Characteristics of the study population
Characteristics of the present study population are
shown in Table 1. Compared to subjects with a low level
of CD34-positive cells, those with high levels demon-
strated a significantly higher prevalence of taking antihy-
pertensive medication as well as higher values for BMI,
LDL, HbA1c, and WBC.




cells (<0.99 cells/μL) p
No. of participants 240 237
Age, years 65.3 ± 2.7 65.6 ± 2.5
Systolic blood pressure, mmHg 135 ± 17 134 ± 18 0.552
Diastolic blood pressure, mmHg 81 ± 11 81 ± 12 0.852
Antihypertensive medication use, % 47.1 38.4 0.031
Body mass index (BMI), kg/m2 23.9 ± 2.8 22.7 ± 3.0 <0.001
Current drinker, % 87.9 87.8 0.954
Current smoker, % 14.2 11.8 0.496
Serum HDL-cholesterol (HDL), mg/dL 57 ± 14 58 ± 13 0.390
Serum LDL-cholesterol (LDL), mg/dL 119 ± 29 110 ± 28 <0.001
Hemoglobin A1c (HbA1c), % 5.8 ± 0.7 5.6 ± 0.5 <0.001
Serum aspartate aminotransferase (AST), IU/L 25 ± 8 26 ± 9 0.282
Serum γ-glutamyltranspeptidase (γ-GTP), IU/L 52 ± 83 47 ± 40 0.370
Serum uric acid (UA), mg/dL 5.9 ± 1.1 5.8 ± 1.2 0.312
Glomerular filtration rate (GFR), mL/min/1.73 m2 76.9 ± 11.2 76.0 ± 12.9 0.926
White blood cells (WBC), cells/μL 6043 ± 1266 4993 ± 1278 <0.001
Values: mean ± standard deviation. p values are age-adjusted values
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Association between HDL and hypertension in total
subjects and after stratification by circulating CD34-
positive cell levels
Table 2 shows the ORs and 95% CIs for hypertension in
relation to HDL in all subjects and as well as those in
subjects stratified by circulating CD34-positive cell levels.
No significant association between HDL-cholesterol and
hypertension in total subjects was noted. Analysis of sub-
jects with high levels of CD34-positive cells, however,
showed that although HDL had no significant association
with hypertension in an age-adjusted model, a significant
positive association was observed after further adjustment
for BMI. This association was unchanged even after
further adjusting for known cardiovascular risk factors.
Additionally, among subjects with a low level of CD34-
positive cells, a tendency toward an association between
HDL and hypertension was observed, although this was
not significant. Even after limiting the analysis to subjects
not taking lipid-lowering medication (201 men with a high
level of CD34-positive cells and 210 men with low CD34-
positive cells), the associations remained unchanged. Age-
adjusted, age- and BMI-adjusted, and fully adjusted ORs
and 95% CIs of hypertension for increments of one stand-
ard deviation (SD) in HDL (13.8 mg/dL) were 1.24 (0.95,
1.62), 1.40 (1.05, 1.86), and 1.44 (1.06, 1.96) for subjects
with a high level of circulating CD34-positive cells; and
0.89 (0.68, 1.17), 1.00 (0.75, 1.33), and 0.87 (0.63, 1.19) for
subjects with low circulating CD34-positive cells.
Association between HDL level and two circulating CD34-
positive cell categories on hypertension
An investigation into the effects of the association
between HDL level and the two CD34-positive cell
categories (high and low) on hypertension revealed a sig-
nificant interaction; p values for the effect of this inter-
action were p = 0.034 for the age-adjusted model, p =
0.025 for the age- and BMI-adjusted model, and p = 0.022
for the fully adjusted model.
Discussion
The major findings of the present study are that, inde-
pendent of known cardiovascular risk factors, HDL is
significantly positively associated with hypertension
among subjects with a high level of CD34-positive cells
but not for subjects with low CD34-positive cells.
A previous Japanese cross-sectional study of 1803
apparently healthy men aged 49.9 ± 9.0 reported a posi-
tive association between HDL and hypertension; the ad-
justed OR and 95% CI of a 1 mg/dL increment of HDL
for hypertension was 1.03 (1.02, 1.04, p < 0.001) [3].
Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for hypertension in relation to HDL-cholesterol stratified by circulating
CD34-positive cell levels
HDL-cholesterol tertiles p for trend 1 SD increment of
HDL (13.8 mg/dL)T1 (low) T2 T3 (high)
Total subjects
No. of participants 161 155 161
No. of cases (%) 101 (62.7) 98 (63.2) 99 (61.5)
Age-adjusted ORs 1.00 1.02 (0.64, 1.61) 0.96 (0.61, 1.51) 0.860 1.05 (0.87, 1.27)
Age- and BMI-adjusted ORs 1.00 1.08 (0.67, 1.72) 1.22 (0.76, 1.96) 0.415 1.19 (0.97, 1.45)
Multivariable ORs 1.00 1.06 (0.66, 1.72) 1.09 (0.66, 1.79) 0.737 1.13 (0.92, 1.40)
High CD34-positive cell (≥0.99 cells/μL)
No. of participants 89 78 73
No. of cases (%) 53 (59.6) 52 (66.7) 51 (69.9)
Age-adjusted ORs 1.00 1.31 (0.69, 2.48) 1.63 (0.84, 3.16) 0.142 1.24 (0.95, 1.62)
Age- and BMI-adjusted ORs 1.00 1.43 (0.75, 2.75) 2.12 (1.05, 4.27) 0.035 1.40 (1.05, 1.86)
Multivariable ORs 1.00 1.48 (0.76, 2.88) 2.34 (1.11, 4.91) 0.025 1.44 (1.06, 1.96)
Low CD34-positive cell (<0.99 cells/μL)
No. of participants 72 77 88
No. of cases (%) 48 (66.7) 46 (59.7) 48 (54.5)
Age-adjusted ORs 1.00 0.77 (0.39, 1.51) 0.60 (0.31, 1.15) 0.123 0.89 (0.68, 1.17)
Age- and BMI-adjusted ORs 1.00 0.76 (0.38, 1.51) 0.72 (0.37, 1.41) 0.345 1.00 (0.75, 1.33)
Multivariable ORs 1.00 0.69 (0.33, 1.44) 0.50 (0.24, 1.05) 0.068 0.87 (0.63, 1.19)
Hypertension is defined as systolic blood pressure ≥140 mmHg, and/or diastolic blood pressure ≥90 mmHg, and/or antihypertensive medication use. Multivariable
ORs: adjusted further for age and BMI, smoking status, alcohol consumption, HbA1C, LDL, AST, γ-GTP, UA and GFR. HDL tertiles are <51 mg/dL for T1, 51–61 mg/
dL for T2, and >61 mg/dL for T3
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Results of this study are compatible with our present
study. Moreover, we found further evidence that the
positive association is limited to subjects with a high
level of CD34-positive cells.
Furthermore, in our present study, although statistical
power did not reach significance initially for subjects
with a high level of CD34-positive cells, after further
adjusting for BMI, the association between HDL and
hypertension became significant. Since HDL is signifi-
cantly inversely correlated with BMI (r = −0.27, p < 0.001)
and a higher BMI is a well-known independent risk factor
for hypertension [31], the unfavorable influence of HDL
might be masked by the favorable influence of lower BMI
status.
The precise mechanism of action governing the associ-
ation between HDL concentration in the blood and
CD34-positive cells on hypertension risk is not under-
stood. One plausible explanation for such an association
is the inhibition of endothelial nitric oxide synthetase
(eNOS) by HDL-cholesterol.
Bone marrow-derived endothelial progenitor cells such
as CD34-positive cells have been reported to contribute to
endothelial repair [11–13]. Endothelial cells establish an
instructive vascular niche that reconstitutes hematopoietic
stem and progenitor cells though the release of specific
paracrine growth factors [32]. Since stimulation of CD34-
positive cell production in the bone marrow is induced by
damage to the endothelium, the number of circulating
CD34-positive cells should increase as a result [33].
Therefore, subjects with a high level of CD34-positive cells
should demonstrate elevated endothelial repair activity in-
duced by endothelial damage. Previous studies reporting the
association of limb ischemia and acute myocardial infarction
with a rapid increase in circulating endothelial progenitor
cells might partly support this mechanism [34, 35].
In addition to the above, unlike HDL from healthy
individuals, HDL from participants with stable cardiovas-
cular disease or acute coronary syndrome inhibits the
eNOS-activating pathway and eNOS-dependent nitric
oxide (NO) production that leads to loss of endothelial
anti-inflammatory effects and endothelial repair [19].
Although HDL exerts vascular-protection via endothelial
progenitor cells [36], our present study found a slight but
significant inverse correlation between HDL and log
CD34-positive cells for subjects with a high level of CD34-
positive cells (r = −0.13, p = 0.047) but not for subjects
with low CD34-positive cells (r = −0.09, p = 0.158).
Therefore, among subjects with a high level of CD34-
positive cells, HDL values should indicate the magnitude
of these unfavorable influences on endothelial repair.
The number of circulating endothelial progenitor cells is
reported to be inversely correlated with the risk factors
for coronary artery disease [37], and the Framingham
risk score [38] also should support this mechanism.
Since hypertension and endothelial dysfunction have a
bidirectional association in which hypertension induces
increased arterial stiffness and vice versa [4–10], an
unfavorable influence on endothelial repair should cause
hypertension among subjects with a high level of CD34-
positive cells.
When an endothelial injury is mild, the necessity of
endothelial repair is small, resulting in a low concentra-
tion of circulating CD34-positive cells. Since subjects
with a small number of CD34-positive cells might have
lower endothelial repair activity induced by endothelial
injury, HDL should stimulate endothelial cell NO pro-
duction [39] and promote endothelial repair mechanisms
[40]. In subjects with a low level of CD34-positive cells,
HDL should act as it does in healthy individuals. There-
fore, in our present study, although the statistical power
was not significant, an inverse tendency was observed
between HDL and hypertension for subjects with a low
level of CD34-positive cells.
Potential limitations of this study warrant consider-
ation. Although hypertension and endothelial dysfunc-
tion have a bidirectional association, no data on the
evaluation of endothelial function was available. To clar-
ify the background mechanism of the association be-
tween HDL and hypertension in relation to circulating
CD34-positive cell levels, further analysis that includes
endothelial function-related data such as flow-mediated
dilation (FMD) will be necessary. Although HDL dem-
onstrates an inverse tendency with hypertension among
subjects with a low level of CD34-positive cells, the stat-
istical power did not reach significance. Further investi-
gation with a larger sample population will be necessary.
Finally, because this was a cross-sectional study, causal
relationships were not able to be established.
Conclusion
In conclusion, we found that HDL is significantly posi-
tively associated with hypertension among subjects with a
high level of CD34-positive cells but not among subjects
with low CD34-positive cells. These results demonstrate
an efficient tool for risk estimation of HDL on cardiovas-
cular events.
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